In this timely and actionable MoneyShow MoneyMasters Podcast episode, host Mike Larson sits down with Jeffrey Hirsch, John McCamant, and Luke Lloyd to discuss the forces shaping the stock market – and the best profit opportunities for the second half of 2026.
First, the panel covers whether the market’s recent rally can continue, why participation is broadening beyond the Magnificent Seven, and what seasonal patterns could mean for stocks during the historically challenging July-through-October period. Then Stock Trader’s Almanac editor-in-chief Jeff explains why he’s taking a more defensive approach. He highlights biotechnology, gold, dividend-paying stocks, consumer staples, and utilities as potential plays.
(To get more articles and podcasts from MoneyShow, subscribe to our Top Pros’ Top Picks newsletter here.)
Luke shares a more bullish outlook, pointing to strong earnings growth, improving market breadth, potential Federal Reserve support, a weakening dollar, and renewed opportunities in small-cap and software stocks. The CEO and founder of Lloyd Financial Group also discusses several of his highest-conviction technology ideas, including Oracle Corp. (ORCL), Akamai Technologies Inc. (AKAM), HubSpot Inc. (HUBS), and Guidewire Software Inc. (GWRE).
John then explores the powerful breakout taking place in biotechnology, increased merger-and-acquisition activity, the relationship between emerging biotech companies and large pharmaceutical firms, and the expanding market for GLP-1 weight-loss drugs, inflammatory-disease treatments, and gene therapies. The editor of the Medical Technology Stock Letter also highlights opportunities like Celldex Therapeutics Inc. (CLDX), Precigen Inc. (PGEN), and Viking Therapeutics Inc. (VKTX).
If you’re looking for actionable stock ideas, sector insights, and contrasting perspectives on where the best profit opportunities lie, this is the panel episode for you!
Other relevant tickers for this podcast include: (ABBV) (AROC) (GD) (GDXJ) (GLD) (IGV) (IWM) (LLY) (NVO) (RSP) (SNEX) and (XBI).Â